Sorry, you need to enable JavaScript to visit this website.

BESPONSA™ (inotuzumab ozogamicin) Principal Display Panel

PRINCIPAL DISPLAY PANEL - 0.9 mg Vial Label

Pfizer

NDC 0008-0100-01
Rx only

BESPONSA
(inotuzumab ozogamicin)
for Injection

0.9 mg/vial

For Intravenous Infusion Only

No Preservatives

Single-dose vial.
Discard unused portion.

PRINCIPAL DISPLAY PANEL - 0.9 mg Vial Label

PRINCIPAL DISPLAY PANEL - 0.9 mg Vial Carton

Pfizer

BESPONSA
(inotuzumab ozogamicin)
for Injection

0.9 mg/vial

Each single-dose vial delivers 0.9 mg
inotuzumab ozogamicin, polysorbate 80
(0.36 mg), sodium chloride (2.16 mg),
sucrose (180 mg), and tromethamine
(8.64 mg).

PRINCIPAL DISPLAY PANEL - 0.9 mg Vial Carton

What's New

No Current Announcements.

Search

Please enter your search term(s) for BESPONSA™